Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression

53Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background and purpose: Proteasome inhibitors represent a novel class of anti-tumour agents that have clinical efficacy against haematological and solid cancers. The anti-apoptotic protein BAG3 is a member of the Bcl-2-associated athanogene family. We have previously shown that BAG3 is up-regulated after exposure to proteasome inhibitors and that inhibition of BAG3 sensitized cells to apoptosis induced by proteasome inhibition. However, the mechanisms by which proteasome inhibition induced BAG3 expression remained unclear and the present experiments were designed to elucidate these mechanisms. Experimental approach: Effects of the proteasome Inhibitor MG132 on activation of mitogenic signalling pathways were evaluated in kidney cancer cells (A498, Caki1, Caki2), with Western blotting. Specific inhibitors against individual mitogenic signalling pathways, real-time reverse transcription-polymerase chain reaction and luciferase reporter assays were used to investigate the roles of mitogenic signalling pathways in BAG3 induction after proteasome inhibition. Cell death was evaluated using Annexin V/propidium iodide staining and subsequent FACS. Key results: MG132 activated several key mitogenic signalling pathways including extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) activities. Induction of BAG3 by MG132 was inhibited by blocking JNK, but not ERK1/2 and p38 MAPK signalling pathways. In addition, SP600125 and dominant-negative JNK1 suppressed BAG3 promoter-driven reporter gene expression. Furthermore, activation of the JNK pathway induced BAG in kidney cancer cells after treatment with MG132. Conclusions and implications: Our results suggested that the JNK pathway was associated with the protective response against proteasome inhibition, by mediating Induction of BAG3. © 2009 The British Pharmacological Society All rights reserved.

References Powered by Scopus

Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions

3752Citations
N/AReaders
Get full text

The regulation of AP-1 activity by mitogen-activated protein kinases

2289Citations
N/AReaders
Get full text

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

700Citations
N/AReaders
Get full text

Cited by Powered by Scopus

BAG3: A multifaceted protein that regulates major cell pathways

268Citations
N/AReaders
Get full text

IKKγ protein is a target of BAG3 regulatory activity in human tumor growth

100Citations
N/AReaders
Get full text

Hsp70 protein complexes as drug targets

96Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wang, H. Q., Liu, B. Q., Gao, Y. Y., Meng, X., Guan, Y., Zhang, H. Y., & Du, Z. X. (2009). Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression. British Journal of Pharmacology, 158(5), 1405–1412. https://doi.org/10.1111/j.1476-5381.2009.00455.x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

70%

Researcher 5

25%

Professor / Associate Prof. 1

5%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 9

50%

Medicine and Dentistry 4

22%

Biochemistry, Genetics and Molecular Bi... 4

22%

Chemistry 1

6%

Save time finding and organizing research with Mendeley

Sign up for free